Authors' Reply

An S De Vriese^{1

2}

Affiliations

¹ Division of Nephrology and Infectious Diseases, AZ Sint-Jan Brugge-Oostende AV, Bruges, Belgium.
² Department of Internal Medicine, Ghent University, Ghent, Belgium.

Comment

An S De Vriese. J Am Soc Nephrol. 2021 Sep.

. 2021 Sep;32(9):2390-2391.

doi: 10.1681/ASN.2021060866. Epub 2021 Aug 18.

An S De Vriese^{1

2}

¹ Division of Nephrology and Infectious Diseases, AZ Sint-Jan Brugge-Oostende AV, Bruges, Belgium.
² Department of Internal Medicine, Ghent University, Ghent, Belgium.

No abstract available

Keywords: cardiovascular disease; cardiovascular events; hemodialysis; randomized controlled trials; renal transplantation.

Comment on

Safety and Efficacy of Vitamin K Antagonists versus Rivaroxaban in Hemodialysis Patients with Atrial Fibrillation: A Multicenter Randomized Controlled Trial.
De Vriese AS, Caluwé R, Van Der Meersch H, De Boeck K, De Bacquer D. De Vriese AS, et al. J Am Soc Nephrol. 2021 Jun 1;32(6):1474-1483. doi: 10.1681/ASN.2020111566. Epub 2021 Mar 22. J Am Soc Nephrol. 2021. PMID: 33753537 Free PMC article. Clinical Trial.
Addressing Transplant Candidacy When Evaluating Safety of Direct Oral Anticoagulant Agents in Patients on Hemodialysis.
Heher E, Elias N. Heher E, et al. J Am Soc Nephrol. 2021 Sep;32(9):2389-2390. doi: 10.1681/ASN.2021060814. Epub 2021 Aug 18. J Am Soc Nephrol. 2021. PMID: 34410934 Free PMC article. No abstract available.

1. Connolly SJ, Crowther M, Eikelboom JW, Gibson CM, Curnutte JT, Lawrence JH, et al. .; ANNEXA-4 Investigators : Full study report of andexanet alfa for bleeding associated with factor Xa inhibitors. N Engl J Med 380: 1326–1335, 2019 - PMC - PubMed
1. Schultz NH, Lundblad R, Holme PA: Activated prothrombin complex concentrate to reverse the factor Xa inhibitor (apixaban) effect before emergency surgery: A case series. J Med Case Reports 12: 138, 2018 - PMC - PubMed
1. Lichvar AB, Pierce DR, Salerno D, Klem P, Waldman G, Park JM: Utilization of direct-acting oral anticoagulation in solid organ transplant patients: A national survey of institutional practices. Clin Transplant 34: e13853, 2020 - PubMed
1. De Vriese AS, Caluwé R, Van Der Meersch H, De Boeck K, De Bacquer D: Safety and efficacy of vitamin K antagonists versus rivaroxaban in hemodialysis patients with atrial fibrillation: A multicenter randomized controlled trial. J Am Soc Nephrol 32: 1474–1483, 2021 - PMC - PubMed
1. De Vriese AS, Heine G: Anticoagulation management in hemodialysis patients with atrial fibrillation: Evidence and opinion [published online ahead of print February 27, 2021]. Nephrol Dial Transplant - PubMed